MAPT and Alzheimer disease: In fact, a multitude of polymorphic nanoparticles when functionalized with molecules/agents such as curcumin, methylene blue, resveratrol, quercetin and polyphenols have been shown to attenuate Aβ/tau aggregation and toxicity in cellular or animal models of AD by improving the BBB permeability or binding affinity18–21.